What this means
This study is still recruiting people, and no results have been posted yet. It will look at how frailty scores change after chemotherapy given before surgery.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 55 and over
- Where
- 1 site, including North Carolina
The science
- Registered title
- The Better, Harder, Faster, Stronger Study
- Trial ID
- NCT07220512 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Frailty at Older Adults, Ovarian Cancer, Endometrial Cancer, Cognitive Dysfunction, Neoadjuvant Chemotherapy
- What is tested
- data collection
- Sponsor
- Wake Forest University Health Sciences
- Ages
- 55 Years to no maximum
- Dates
- First posted Oct 24, 2025 · updated Jul 15, 2026
Registry summary
The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in participants with advanced ovarian and endometrial cancer.
Sites (1)
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States